PRELUDE CAPITAL MANAGEMENT, LLC - LUX HEALTH TECH ACQUISITION ownership

LUX HEALTH TECH ACQUISITION's ticker is LUXA and the CUSIP is 55068A100. A total of 59 filers reported holding LUX HEALTH TECH ACQUISITION in Q3 2021. The put-call ratio across all filers is 0.13 and the average weighting 1.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of LUX HEALTH TECH ACQUISITION
ValueSharesWeighting
Q1 2022$992,000
-32.8%
100,600
-33.2%
0.03%
-23.7%
Q4 2021$1,476,000
-10.3%
150,600
-10.2%
0.04%
-9.5%
Q3 2021$1,645,000
+139.8%
167,700
+141.8%
0.04%
+110.0%
Q2 2021$686,000
+566.0%
69,357
+593.6%
0.02%
+566.7%
Q1 2021$103,00010,0000.00%
Other shareholders
LUX HEALTH TECH ACQUISITION shareholders Q3 2021
NameSharesValueWeighting ↓
Wolfswood Holdings, LLC 2,000,000$19,720,00081.59%
MYDA Advisors LLC 970,000$9,564,0003.78%
RP Investment Advisors LP 1,309,486$12,912,0001.81%
Tuttle Capital Management, LLC 41,697$411,0001.02%
Silver Rock Financial LP 369,442$3,643,0000.69%
Empyrean Capital Partners, LP 3,000,649$29,586,0000.65%
BBR PARTNERS, LLC 639,999$6,310,0000.60%
Governors Lane LP 725,000$7,149,0000.52%
Spartan Fund Management Inc. 226,753$2,795,0000.46%
Senator Investment Group LP 1,473,600$14,530,0000.45%
View complete list of LUX HEALTH TECH ACQUISITION shareholders